AMANDA PRESSLEY: Open Payments
NPI 1093376709 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 28 payments from 14 companies in 2025. Trend: 2023 $233 · 2024 $561 · 2025 $999
Food & beverage: $910Education: $89
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $169 |
| BridgeBio Pharma, Inc. | 2 | $150 |
| Actelion Pharmaceuticals US, Inc. | 3 | $130 |
| Boston Scientific Corporation | 2 | $120 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| United Therapeutics Corporation | 1 | $62 |
| CVRx, Inc. | 2 | $52 |
| Abbott Laboratories | 2 | $42 |
| Amgen Inc. | 2 | $39 |
Products named: Kerendia, Attruby, OPSUMIT, WATCHMAN FLX, VERQUVO, LEQVIO, Tyvaso, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
